Myriad Genetics Inc.
MYGN | NASDAQ
$4.01
+$0.12 (+3.08%)
At close: Sep 21, 2026, 4:00 PM ET
$3.87
-$0.14 (-3.49%)
Pre-market:
Sep 22, 2026, 8:53 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -1.55 | -9.72 | -6.02 | -10.44 | -78.86 | -6.61 |
PEG Ratio | -0.01 | 0.17 | -0.05 | -0.04 | 0.89 | -0.58 |
PS Ratio | 0.70 | 1.48 | 2.10 | 1.72 | 3.11 | 2.65 |
PB Ratio | 1.56 | 1.77 | 2.02 | 1.32 | 2.22 | 1.68 |
P/FCF Ratio | -22.41 | -32.35 | -8.60 | -7.71 | 3.57K | -36.83 |
P/OCF Ratio | 318.77 | -142.77 | -14.29 | -11 | 115.32 | -54.90 |
OCF/S Ratio | 0.22 | -1.04 | -14.72 | -15.67 | 2.69 | -4.83 |
Debt / Equity Ratio | 0.57 | 0.20 | 0.19 | 0.16 | 0.10 | 0.33 |
Quick Ratio | 2.26 | 1.65 | 1.87 | 1.85 | 2.30 | 2.48 |
Current Ratio | 2.49 | 1.82 | 2.01 | 2 | 2.37 | 2.67 |
Asset Turnover | 1.17 | 0.82 | 0.66 | 0.57 | 0.52 | 0.39 |
Interest Coverage | -6.46 | -31.29 | -88.76 | -36.97 | -28.86 | n/a |
Return on Equity | -99.43% | -18.16% | -33.62% | -12.64% | -2.81% | -25.39% |
Return on Assets | -51.78% | -12.39% | -22.97% | -9.34% | -2.06% | -15.77% |
Return on Invested Capital | -10.83% | -10% | -25.57% | -8.76% | -8.03% | -15.14% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 69.93% | 69.89% | 68.64% | 70.22% | 71.39% | 68.01% |
Net Profit Margin | -44.38% | -15.20% | -34.96% | -16.51% | -3.94% | -40.16% |
Pretax Profit Margin | -47.92% | -14.74% | -34.81% | -20.73% | -8.27% | -50.93% |
Operating Profit Margin | -8.22% | -10.46% | -34.17% | -17.44% | -27.58% | -34.97% |
FCF Margin | -3.10% | -4.58% | -24.46% | -22.35% | 0.09% | -7.20% |
EBITDA Margin | -40.13% | -7.10% | -26.21% | -12.49% | 1.78% | -22.15% |
Add to Watchlist
Select watchlists to add or remove MYGN